Bio-Rad Laboratories Common Stock Net 2010-2025 | BIO
Bio-Rad Laboratories common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
- Bio-Rad Laboratories common stock net for the quarter ending June 30, 2025 was $0M, a 100% decline year-over-year.
- Bio-Rad Laboratories common stock net for 2024 was $0B, a 0% decline from 2023.
- Bio-Rad Laboratories common stock net for 2023 was $0B, a 100% decline from 2022.
- Bio-Rad Laboratories common stock net for 2022 was $0B, a 0% decline from 2021.
| Bio-Rad Laboratories Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| Bio-Rad Laboratories Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-06-30 | |
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $0 |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $0 |
| 2011-09-30 | $0 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| 2010-12-31 | $0 |
| 2010-09-30 | $0 |
| 2010-06-30 | $0 |
| 2010-03-31 | $0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $0 |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.804B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.435B | 26.79 |
| Boston Scientific (BSX) | United States | $153.732B | 36.66 |
| Stryker (SYK) | United States | $149.077B | 30.35 |
| EssilorLuxottica (ESLOY) | France | $146.011B | 0.00 |
| Medtronic (MDT) | Ireland | $115.234B | 16.26 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.493B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.717B | 24.97 |
| ResMed (RMD) | United States | $41.881B | 29.95 |
| Agilent Technologies (A) | United States | $34.119B | 22.24 |
| GE HealthCare Technologies (GEHC) | United States | $33.772B | 15.87 |
| Terumo (TRUMY) | Japan | $27.820B | 32.97 |
| Koninklijke Philips (PHG) | Netherlands | $26.548B | 17.56 |
| Insulet (PODD) | United States | $23.052B | 77.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.663B | 13.15 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.153B | 0.00 |
| Baxter (BAX) | United States | $12.496B | 9.65 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.750B | 10.14 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.442B | 24.08 |
| Perrigo (PRGO) | Ireland | $3.247B | 8.11 |
| Prestige Consumer Healthcare (PBH) | United States | $3.219B | 14.28 |
| ICU Medical (ICUI) | United States | $3.055B | 20.80 |
| Haemonetics (HAE) | United States | $2.616B | 11.68 |
| LeMaitre Vascular (LMAT) | United States | $2.158B | 46.28 |
| QuidelOrtho (QDEL) | United States | $1.816B | 11.43 |
| AtriCure (ATRC) | United States | $1.781B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.676B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.566B | 67.25 |
| Phibro Animal Health (PAHC) | United States | $1.291B | 16.50 |
| AdaptHealth (AHCO) | United States | $1.279B | 18.17 |
| Neogen (NEOG) | United States | $1.219B | 19.34 |
| Acuren (TIC) | United States | $1.209B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.176B | 2454.00 |
| Tilray Brands (TLRY) | Canada | $1.167B | 0.00 |
| Valneva SE (VALN) | France | $0.975B | 0.00 |
| InMode (INMD) | Israel | $0.896B | 8.29 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| SNDL (SNDL) | Canada | $0.552B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.534B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.506B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.501B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 16.10 |
| Evolus (EOLS) | United States | $0.461B | 0.00 |
| CeriBell (CBLL) | United States | $0.432B | 0.00 |
| Owens & Minor (OMI) | United States | $0.414B | 3.67 |
| Capricor Therapeutics (CAPR) | United States | $0.351B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.315B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.300B | 0.00 |
| Omeros (OMER) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Brainsway (BWAY) | Israel | $0.273B | 55.65 |
| Viemed Healthcare (VMD) | United States | $0.270B | 20.44 |
| Aurora Cannabis (ACB) | Canada | $0.269B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.262B | 0.00 |
| High Tide (HITI) | Canada | $0.248B | 0.00 |
| Quanterix (QTRX) | United States | $0.234B | 0.00 |
| Cerus (CERS) | United States | $0.228B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.217B | 0.00 |
| Exagen (XGN) | United States | $0.212B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Organigram Global (OGI) | Canada | $0.204B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.61 |
| TriSalus Life Sciences (TLSI) | United States | $0.176B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.38 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.103B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.09 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.084B | 0.00 |
| Apyx Medical (APYX) | United States | $0.075B | 0.00 |
| Safety Shot (SHOT) | United States | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.053B | 31.05 |
| Veru (VERU) | United States | $0.047B | 0.00 |
| Zynex (ZYXI) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.42 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.98 |
| Trinity Biotech (TRIB) | Ireland | $0.025B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |